Difficult diagnosis of infliximab-related miliary tuberculosis

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 61, Issue 2, 2004, Pages 128-130

  Contini, S ^a   Raimondi, G ^a,b   Graziano, P ^c   Saltini, C ^a,b   Bocchino, Marialuisa ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Infliximab; Miliary tuberculosis; TNF

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; ETHAMBUTOL; INFLIXIMAB; ISONIAZID; NONSTEROID ANTIINFLAMMATORY AGENT; PYRAZINAMIDE; RIFAMPICIN; STEROID;

ACID FAST BACTERIUM; ADULT; ARTICLE; AUTOPSY; CASE REPORT; DEATH; ELECTROCARDIOGRAM; FEMALE; FEVER; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOSPITAL ADMISSION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; MILIARY TUBERCULOSIS; OPPORTUNISTIC INFECTION; RESPIRATORY TRACT DISEASE; RHEUMATIC DISEASE; THORAX RADIOGRAPHY;

EID: 6344240933     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2004.712     Document Type: Article

References (16)

1. Schema AA, Megeff C. New drugs for the treatment of rheumatoid arthritis. Am J Health Syst Pharm 2000; 57: 225-234.
2. Criscione LG, St Clair EW. Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases. Curr Opin Rheumatol 2002; 14: 204-211.
3. Knight JC, Kwiatkowski D. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians 1999; 111: 290-298.
4. Bresnihan B, Cunnane G. Infection complications associated with the use of biologic agents. Rheum Dis Clin North Am 2003; 29: 185-202.
5. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 2001; 345: 1098-1104.
6. Remicade for Chron's disease. Med Lett Drugs Ther 1999; 41: 19-20.
7. Rovere Quercini P, Vecellio M, Sabbadini MG, Ciboddo G. Miliary tuberculosis after biological therapy for rheumatoid arthritis. Rheumatology 2002; 41: 231.
8. Vonkeman HE, van der Valk PD, Mulder L, van der Valk PD, Mulder L, van de Laar MA. Fatal miliary tuberculosis during treatment with infliximab. Ned Tijdschr Geneeskd 2002; 146: 1196-1199.
9. Mayordomo L, Marengo JL, Gomez-Mateos J, Rejon E. Pulmonary miliary tuberculosis in a patient with anti-TNF alpha treatment. Scand J Rheumatol 2002; 31: 44-45.
10. Alsoub H, Alousi FS. Miliary tuberculosis in Quatar: a review of 32 adult cases. Ann Saudi Med 2001; 21: 16-20.
11. Veiga Gonzalez M, Riestra Martinez M, Fresno Forcelledo M, Gonzalez Gonzalez M, Ablanedo Ablanedo P, Herrero Zapatero A. Miliary tuberculosis: autopsy study of 29 cases. An Med Interna 1995; 12: 17-20.
12. Mert A, Bilir M, Tabak F, Ozaras F, et al. Miliary tuberculosis: clinical manifestations, diagnosis and outcome in 38 adults. Respirology 2001; 6: 217-224.
13. Ibanez Martinez J, Bautista Ojeda MD, Saez Torrez C, Jorda I Heras M, Ayerza Lerchundi MA, Pachion Diaz J. Multicenter study of tuberculosis in clinical autopsies in Andalucia, in the 1973-1988 period. Rev Clin Esp 1991; 188: 273-277.
14. Grinsztejn B, Fandinho FC, Veloso VG, et al. Mycobacteremia in patients with the acquired immunodeficiency syndrome. Arch Intern Med 1997; 157: 2359-2363.
15. Lado-Lado FL, Barrio Gomez E, Carballo Arceo E, Cabarcos Ortiz de Barron A. Pulmonary tuberculosis with normal chest radiographs in HIV-immunodeficient patients. AIDS 1999; 13: 1146-1147.
16. Lado-Lado FL, Barrio Gomez E, Carballo Arceo E, Cabarcos Ortiz de Barron A. Clinical presentation of tuberculosis and the degree of immunodeficiency in patients with HIV infection. Scand J Infect Dis 1999; 31: 387-391.